Prevention of Diabetes in Overweight/Obese Adults through Traditional Chinese Patent Medicine: Study Protocol for a Prospective Cohort Study
Background. Early intervention in prediabetes can prevent or delay the incidence of type 2 diabetes mellitus (T2DM). Traditional Chinese patent medicine (TCPM) is widely used in China to prevent T2DM. This study aims to evaluate the efficacy and safety of TCPMs for preventing T2DM. Method/Design. Th...
Gespeichert in:
| Veröffentlicht in: | Evidence-based complementary and alternative medicine 2021, Vol.2021, p.6006802-8 |
|---|---|
| Hauptverfasser: | , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 8 |
|---|---|
| container_issue | |
| container_start_page | 6006802 |
| container_title | Evidence-based complementary and alternative medicine |
| container_volume | 2021 |
| creator | Pang, Bing Zhang, Yue-Ying Hu, Hua-Jie Sun, Ye Cao, Ai-Mei Lu, Chun-Qian Zhang, Wei-Hua Ni, Qing |
| description | Background. Early intervention in prediabetes can prevent or delay the incidence of type 2 diabetes mellitus (T2DM). Traditional Chinese patent medicine (TCPM) is widely used in China to prevent T2DM. This study aims to evaluate the efficacy and safety of TCPMs for preventing T2DM. Method/Design. This study is a multicenter, cohort study with two arms. A total of 600 participants will be recruited. The participants will be divided into either intervention or control groups according to their own desire, and the exposure factor is the application of TCPMs. All participants will be encouraged to lead a healthy lifestyle, and the intervention group also used TCPMs based on syndrome differentiation. Incident diabetes and normalization of blood glucose are indexes of end point. Safety assessments and adverse event monitoring will also be conducted. The treatment duration is set for 24 weeks, and we will follow-up for another 2 years. Discussion. This trial may provide initial evidence regarding the efficacy and safety of TCPMs plus lifestyle intervention (LI) compared to LI alone for preventing T2DM and provide a comprehensive intervention plans that choose suitable TCPMs for diabetes prevention according to syndrome differentiation. Trial Registration Number. Chinese Clinical Trial Registry ID: ChiCTR1900023541, registered on 1 Jun 2019. The version identifier is 2018121702. |
| doi_str_mv | 10.1155/2021/6006802 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2638022275</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2600066128</sourcerecordid><originalsourceid>FETCH-LOGICAL-c350t-9ab3269966dff280cb795ff8dfd08af5a0879e7c41e8cf84d2195cd1b8d23afa3</originalsourceid><addsrcrecordid>eNp90U1r2zAYB3BRNvq23Xoegl0GbRZJtix5t5K226AjgXXQm5GlR7WKY6WSnNLvsA89mWQ97LCTXvjpD3r-CJ1R8plSzueMMDqvCKkkYQfomIqSzkom5ZvXvbg_QicxPhLCaiHEIToqOKs4Lekx-r0KsIUhOT9gb_GVUy0kiNgNeLmF8AzuoUvzZQsR8KUZ-xRx6oIfHzp8F5Rx00PV40XnhomsVMph-AcYp_PNF_wzjeYFr4JPXvseWx-wmo5xAzq5LeCF73xIO_cOvbWqj_B-v56iXzfXd4tvs9vl1--Ly9uZLjhJs1q1BavquqqMtUwS3YqaWyuNNUQqyxWRogahSwpSW1kaRmuuDW2lYYWyqjhFn3a5m-CfRoipWbuooe_VAH6MDauKPEzGBM_04z_00Y8hf3lSJE-9okxmdbFTOv8sBrDNJri1Ci8NJc3UUjO11OxbyvzDPnRs12Be8d9aMjjfgTxWo57d_-P-AIBtm0U</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2600066128</pqid></control><display><type>article</type><title>Prevention of Diabetes in Overweight/Obese Adults through Traditional Chinese Patent Medicine: Study Protocol for a Prospective Cohort Study</title><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central Open Access</source><source>Wiley Online Library (Open Access Collection)</source><source>PubMed Central</source><source>Alma/SFX Local Collection</source><creator>Pang, Bing ; Zhang, Yue-Ying ; Hu, Hua-Jie ; Sun, Ye ; Cao, Ai-Mei ; Lu, Chun-Qian ; Zhang, Wei-Hua ; Ni, Qing</creator><contributor>Salem, Mohamed Z.M. ; Mohamed ZM Salem</contributor><creatorcontrib>Pang, Bing ; Zhang, Yue-Ying ; Hu, Hua-Jie ; Sun, Ye ; Cao, Ai-Mei ; Lu, Chun-Qian ; Zhang, Wei-Hua ; Ni, Qing ; Salem, Mohamed Z.M. ; Mohamed ZM Salem</creatorcontrib><description>Background. Early intervention in prediabetes can prevent or delay the incidence of type 2 diabetes mellitus (T2DM). Traditional Chinese patent medicine (TCPM) is widely used in China to prevent T2DM. This study aims to evaluate the efficacy and safety of TCPMs for preventing T2DM. Method/Design. This study is a multicenter, cohort study with two arms. A total of 600 participants will be recruited. The participants will be divided into either intervention or control groups according to their own desire, and the exposure factor is the application of TCPMs. All participants will be encouraged to lead a healthy lifestyle, and the intervention group also used TCPMs based on syndrome differentiation. Incident diabetes and normalization of blood glucose are indexes of end point. Safety assessments and adverse event monitoring will also be conducted. The treatment duration is set for 24 weeks, and we will follow-up for another 2 years. Discussion. This trial may provide initial evidence regarding the efficacy and safety of TCPMs plus lifestyle intervention (LI) compared to LI alone for preventing T2DM and provide a comprehensive intervention plans that choose suitable TCPMs for diabetes prevention according to syndrome differentiation. Trial Registration Number. Chinese Clinical Trial Registry ID: ChiCTR1900023541, registered on 1 Jun 2019. The version identifier is 2018121702.</description><identifier>ISSN: 1741-427X</identifier><identifier>EISSN: 1741-4288</identifier><identifier>DOI: 10.1155/2021/6006802</identifier><identifier>PMID: 35265141</identifier><language>eng</language><publisher>United States: Hindawi</publisher><subject>Adverse events ; Body weight ; Chinese medicine ; Clinical medicine ; Cohort analysis ; Diabetes ; Diabetes mellitus (non-insulin dependent) ; Disease prevention ; Exercise ; Glucose ; Glucose monitoring ; Intervention ; Lifestyles ; Obesity ; Overweight ; Safety ; Weight control</subject><ispartof>Evidence-based complementary and alternative medicine, 2021, Vol.2021, p.6006802-8</ispartof><rights>Copyright © 2021 Bing Pang et al.</rights><rights>Copyright © 2021 Bing Pang et al. This is an open access article distributed under the Creative Commons Attribution License (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. https://creativecommons.org/licenses/by/4.0</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c350t-9ab3269966dff280cb795ff8dfd08af5a0879e7c41e8cf84d2195cd1b8d23afa3</cites><orcidid>0000-0002-3128-5622 ; 0000-0001-6908-1951 ; 0000-0001-8686-1597 ; 0000-0002-6448-6623 ; 0000-0002-0069-5055 ; 0000-0002-5197-4126 ; 0000-0003-2079-5317 ; 0000-0002-4786-4901</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,4024,27923,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/35265141$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><contributor>Salem, Mohamed Z.M.</contributor><contributor>Mohamed ZM Salem</contributor><creatorcontrib>Pang, Bing</creatorcontrib><creatorcontrib>Zhang, Yue-Ying</creatorcontrib><creatorcontrib>Hu, Hua-Jie</creatorcontrib><creatorcontrib>Sun, Ye</creatorcontrib><creatorcontrib>Cao, Ai-Mei</creatorcontrib><creatorcontrib>Lu, Chun-Qian</creatorcontrib><creatorcontrib>Zhang, Wei-Hua</creatorcontrib><creatorcontrib>Ni, Qing</creatorcontrib><title>Prevention of Diabetes in Overweight/Obese Adults through Traditional Chinese Patent Medicine: Study Protocol for a Prospective Cohort Study</title><title>Evidence-based complementary and alternative medicine</title><addtitle>Evid Based Complement Alternat Med</addtitle><description>Background. Early intervention in prediabetes can prevent or delay the incidence of type 2 diabetes mellitus (T2DM). Traditional Chinese patent medicine (TCPM) is widely used in China to prevent T2DM. This study aims to evaluate the efficacy and safety of TCPMs for preventing T2DM. Method/Design. This study is a multicenter, cohort study with two arms. A total of 600 participants will be recruited. The participants will be divided into either intervention or control groups according to their own desire, and the exposure factor is the application of TCPMs. All participants will be encouraged to lead a healthy lifestyle, and the intervention group also used TCPMs based on syndrome differentiation. Incident diabetes and normalization of blood glucose are indexes of end point. Safety assessments and adverse event monitoring will also be conducted. The treatment duration is set for 24 weeks, and we will follow-up for another 2 years. Discussion. This trial may provide initial evidence regarding the efficacy and safety of TCPMs plus lifestyle intervention (LI) compared to LI alone for preventing T2DM and provide a comprehensive intervention plans that choose suitable TCPMs for diabetes prevention according to syndrome differentiation. Trial Registration Number. Chinese Clinical Trial Registry ID: ChiCTR1900023541, registered on 1 Jun 2019. The version identifier is 2018121702.</description><subject>Adverse events</subject><subject>Body weight</subject><subject>Chinese medicine</subject><subject>Clinical medicine</subject><subject>Cohort analysis</subject><subject>Diabetes</subject><subject>Diabetes mellitus (non-insulin dependent)</subject><subject>Disease prevention</subject><subject>Exercise</subject><subject>Glucose</subject><subject>Glucose monitoring</subject><subject>Intervention</subject><subject>Lifestyles</subject><subject>Obesity</subject><subject>Overweight</subject><subject>Safety</subject><subject>Weight control</subject><issn>1741-427X</issn><issn>1741-4288</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>RHX</sourceid><sourceid>8G5</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNp90U1r2zAYB3BRNvq23Xoegl0GbRZJtix5t5K226AjgXXQm5GlR7WKY6WSnNLvsA89mWQ97LCTXvjpD3r-CJ1R8plSzueMMDqvCKkkYQfomIqSzkom5ZvXvbg_QicxPhLCaiHEIToqOKs4Lekx-r0KsIUhOT9gb_GVUy0kiNgNeLmF8AzuoUvzZQsR8KUZ-xRx6oIfHzp8F5Rx00PV40XnhomsVMph-AcYp_PNF_wzjeYFr4JPXvseWx-wmo5xAzq5LeCF73xIO_cOvbWqj_B-v56iXzfXd4tvs9vl1--Ly9uZLjhJs1q1BavquqqMtUwS3YqaWyuNNUQqyxWRogahSwpSW1kaRmuuDW2lYYWyqjhFn3a5m-CfRoipWbuooe_VAH6MDauKPEzGBM_04z_00Y8hf3lSJE-9okxmdbFTOv8sBrDNJri1Ci8NJc3UUjO11OxbyvzDPnRs12Be8d9aMjjfgTxWo57d_-P-AIBtm0U</recordid><startdate>2021</startdate><enddate>2021</enddate><creator>Pang, Bing</creator><creator>Zhang, Yue-Ying</creator><creator>Hu, Hua-Jie</creator><creator>Sun, Ye</creator><creator>Cao, Ai-Mei</creator><creator>Lu, Chun-Qian</creator><creator>Zhang, Wei-Hua</creator><creator>Ni, Qing</creator><general>Hindawi</general><general>Hindawi Limited</general><scope>RHU</scope><scope>RHW</scope><scope>RHX</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7T5</scope><scope>7TO</scope><scope>7X7</scope><scope>7XB</scope><scope>88G</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>H94</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M2M</scope><scope>M2O</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PSYQQ</scope><scope>Q9U</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-3128-5622</orcidid><orcidid>https://orcid.org/0000-0001-6908-1951</orcidid><orcidid>https://orcid.org/0000-0001-8686-1597</orcidid><orcidid>https://orcid.org/0000-0002-6448-6623</orcidid><orcidid>https://orcid.org/0000-0002-0069-5055</orcidid><orcidid>https://orcid.org/0000-0002-5197-4126</orcidid><orcidid>https://orcid.org/0000-0003-2079-5317</orcidid><orcidid>https://orcid.org/0000-0002-4786-4901</orcidid></search><sort><creationdate>2021</creationdate><title>Prevention of Diabetes in Overweight/Obese Adults through Traditional Chinese Patent Medicine: Study Protocol for a Prospective Cohort Study</title><author>Pang, Bing ; Zhang, Yue-Ying ; Hu, Hua-Jie ; Sun, Ye ; Cao, Ai-Mei ; Lu, Chun-Qian ; Zhang, Wei-Hua ; Ni, Qing</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c350t-9ab3269966dff280cb795ff8dfd08af5a0879e7c41e8cf84d2195cd1b8d23afa3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Adverse events</topic><topic>Body weight</topic><topic>Chinese medicine</topic><topic>Clinical medicine</topic><topic>Cohort analysis</topic><topic>Diabetes</topic><topic>Diabetes mellitus (non-insulin dependent)</topic><topic>Disease prevention</topic><topic>Exercise</topic><topic>Glucose</topic><topic>Glucose monitoring</topic><topic>Intervention</topic><topic>Lifestyles</topic><topic>Obesity</topic><topic>Overweight</topic><topic>Safety</topic><topic>Weight control</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Pang, Bing</creatorcontrib><creatorcontrib>Zhang, Yue-Ying</creatorcontrib><creatorcontrib>Hu, Hua-Jie</creatorcontrib><creatorcontrib>Sun, Ye</creatorcontrib><creatorcontrib>Cao, Ai-Mei</creatorcontrib><creatorcontrib>Lu, Chun-Qian</creatorcontrib><creatorcontrib>Zhang, Wei-Hua</creatorcontrib><creatorcontrib>Ni, Qing</creatorcontrib><collection>Hindawi Publishing Complete</collection><collection>Hindawi Publishing Subscription Journals</collection><collection>Hindawi Publishing Open Access Journals</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing & Allied Health Database</collection><collection>Immunology Abstracts</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Psychology Database (Alumni)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Psychology Database</collection><collection>Research Library</collection><collection>Research Library (Corporate)</collection><collection>Nursing & Allied Health Premium</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest One Psychology</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>Evidence-based complementary and alternative medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Pang, Bing</au><au>Zhang, Yue-Ying</au><au>Hu, Hua-Jie</au><au>Sun, Ye</au><au>Cao, Ai-Mei</au><au>Lu, Chun-Qian</au><au>Zhang, Wei-Hua</au><au>Ni, Qing</au><au>Salem, Mohamed Z.M.</au><au>Mohamed ZM Salem</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Prevention of Diabetes in Overweight/Obese Adults through Traditional Chinese Patent Medicine: Study Protocol for a Prospective Cohort Study</atitle><jtitle>Evidence-based complementary and alternative medicine</jtitle><addtitle>Evid Based Complement Alternat Med</addtitle><date>2021</date><risdate>2021</risdate><volume>2021</volume><spage>6006802</spage><epage>8</epage><pages>6006802-8</pages><issn>1741-427X</issn><eissn>1741-4288</eissn><abstract>Background. Early intervention in prediabetes can prevent or delay the incidence of type 2 diabetes mellitus (T2DM). Traditional Chinese patent medicine (TCPM) is widely used in China to prevent T2DM. This study aims to evaluate the efficacy and safety of TCPMs for preventing T2DM. Method/Design. This study is a multicenter, cohort study with two arms. A total of 600 participants will be recruited. The participants will be divided into either intervention or control groups according to their own desire, and the exposure factor is the application of TCPMs. All participants will be encouraged to lead a healthy lifestyle, and the intervention group also used TCPMs based on syndrome differentiation. Incident diabetes and normalization of blood glucose are indexes of end point. Safety assessments and adverse event monitoring will also be conducted. The treatment duration is set for 24 weeks, and we will follow-up for another 2 years. Discussion. This trial may provide initial evidence regarding the efficacy and safety of TCPMs plus lifestyle intervention (LI) compared to LI alone for preventing T2DM and provide a comprehensive intervention plans that choose suitable TCPMs for diabetes prevention according to syndrome differentiation. Trial Registration Number. Chinese Clinical Trial Registry ID: ChiCTR1900023541, registered on 1 Jun 2019. The version identifier is 2018121702.</abstract><cop>United States</cop><pub>Hindawi</pub><pmid>35265141</pmid><doi>10.1155/2021/6006802</doi><tpages>8</tpages><orcidid>https://orcid.org/0000-0002-3128-5622</orcidid><orcidid>https://orcid.org/0000-0001-6908-1951</orcidid><orcidid>https://orcid.org/0000-0001-8686-1597</orcidid><orcidid>https://orcid.org/0000-0002-6448-6623</orcidid><orcidid>https://orcid.org/0000-0002-0069-5055</orcidid><orcidid>https://orcid.org/0000-0002-5197-4126</orcidid><orcidid>https://orcid.org/0000-0003-2079-5317</orcidid><orcidid>https://orcid.org/0000-0002-4786-4901</orcidid><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1741-427X |
| ispartof | Evidence-based complementary and alternative medicine, 2021, Vol.2021, p.6006802-8 |
| issn | 1741-427X 1741-4288 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_2638022275 |
| source | Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central Open Access; Wiley Online Library (Open Access Collection); PubMed Central; Alma/SFX Local Collection |
| subjects | Adverse events Body weight Chinese medicine Clinical medicine Cohort analysis Diabetes Diabetes mellitus (non-insulin dependent) Disease prevention Exercise Glucose Glucose monitoring Intervention Lifestyles Obesity Overweight Safety Weight control |
| title | Prevention of Diabetes in Overweight/Obese Adults through Traditional Chinese Patent Medicine: Study Protocol for a Prospective Cohort Study |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T09%3A16%3A49IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Prevention%20of%20Diabetes%20in%20Overweight/Obese%20Adults%20through%20Traditional%20Chinese%20Patent%20Medicine:%20Study%20Protocol%20for%20a%20Prospective%20Cohort%20Study&rft.jtitle=Evidence-based%20complementary%20and%20alternative%20medicine&rft.au=Pang,%20Bing&rft.date=2021&rft.volume=2021&rft.spage=6006802&rft.epage=8&rft.pages=6006802-8&rft.issn=1741-427X&rft.eissn=1741-4288&rft_id=info:doi/10.1155/2021/6006802&rft_dat=%3Cproquest_cross%3E2600066128%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2600066128&rft_id=info:pmid/35265141&rfr_iscdi=true |